TITLE

Spinal Epidural Haematoma Related to Oral Anticoagulant Overdose A Case Report

AUTHOR(S)
Bayir, A.; Akilli, B.; Cengiz, S. L.
PUB. DATE
June 2008
SOURCE
Neuroradiology Journal;Jun2008, Vol. 21 Issue 3, p368
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The most important complication during the treatment of oral anticoagulants is bleeding and it is seen most commonly in the skin, urinary system, gastrointestinal tract and central nervous system. Spinal epidural bleeding related to oral coagulant overdose is a rare complication and it may require urgent surgical treatment depending on the neurological clinical chart. This paper describes a patient with spinal epidural haematoma defined by imaging methods due to paraparesis which developed during oral coagulant usage and its treatment.
ACCESSION #
38011771

 

Related Articles

  • Spontaneous Cervical Epidural Hematoma Associated With Oral Anticoagulant Therapy. Vay�, Amparo; Resurecci�n, Manuel; Ricart, Jos� Ma; Ortu�o, Carmen; Ripoll, Francisco; Mira, Yolanda; Aznar, Justo // Clinical & Applied Thrombosis/Hemostasis;Apr2001, Vol. 7 Issue 2, p166 

    A 54-year-old woman who was on anticoagulant treatment with acenocoumarol for a mitral prothesis developed a cervical spinal epidural hematoma. probably triggered by coughing fits together with supratherapeutic anticoagulation. Because of the subacute evolution of the hematoma. it was not...

  • Clopidogrel/enoxaparin sodium.  // Reactions Weekly;7/17/2010, Issue 1310, p17 

    The article describes two cases of epidural haematoma induced by anticoagulant therapy with enoxaparin sodium and/or clopidgrel.

  • Dabigatran etexilate overdose.  // Reactions Weekly;Aug2015, Vol. 1563 Issue 1, p74 

    The article presents a case study of an 81-year-old woman who experienced abnormal coagulation tests following an overdosage of dabigatran etexilate for non-valvular atrial fibrillation and moderate chronic renal impairment.

  • Vitamin K antagonist overdose.  // Reactions Weekly;9/13/2008, Issue 1219, p35 

    The article describes the case of a 77-year-old woman who developed an intramural duodenal haematoma after receiving an overdose of a vitamin K antagonist for anticoagulation. The patient was admitted for treatment of leg ulcers, but due to a history of atrial fibrillation, she was given a...

  • Atrial Fibrillation, Stroke and Anticoagulant Use. Jayaraman, Chandra; Fisher, Raewyn; Friedman, Paul; Devlin, Gerard // Heart, Lung & Circulation;Sep2004, Vol. 13 Issue 3, p252 

    Background. Ischaemic stroke is reduced by anticoagulant therapy in high-risk patients with atrial fibrillation. Evidence however, suggests patients are under treated.Aim. To assess anticoagulant use in patients with ischaemic stroke and atrial fibrillation in Waikato Hospital.Methods. A...

  • A MOUSE MINUS CLOTTING FACTOR GENE. Kingman, Sharon // BioWorld Today;2/11/2014, Vol. 25 Issue 28, p9 

    The article focuses on the anticoagulation therapy experiments using the antibody 3F7 developed in 2005 by Swedish, Australian and German researchers. The study showed that mice which were manipulated genetically to block the clotting factor XII were protected from the development of thrombosis....

  • Commentary. Crowther, Mark // Evidence Based Medicine;Apr2007, Vol. 12 Issue 2, p45 

    The article expresses the author's view on the publication of the study on the risk factors that predict recurrent venous thromboembolism (VTE). The author mentions that the issue on the optimal duration of oral coagulation therapy is still being debated because of its risk, the benefit ratio of...

  • Novel anticoagulation strategies prove cost effective.  // PharmacoEconomics & Outcomes News;10/21/2006, Issue 514, p5 

    The article reveals that novel approaches to anticoagulation therapy management may provide cost-effective alternatives to traditional care, according to U.S. studies. Researches showed that anticoagulation monitoring has resulted in an expected cost and effectiveness of $US8,661 and 6.617...

  • tirofiban.  // Royal Society of Medicine: Medicines;2002, p536 

    This article provides information on tirofiban which can be used to prevent thrombosis or blood-clot formation. The antithrombic drug works by stopping platelets sticking to one another or to the walls of blood vessels. It can be used together with heparin and aspirin to prevent thrombosis in...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics